The first made-in-India C-295 military transport aircraft successfully completed its maiden flight, the Indian Air Force (IAF) said on Wednesday (June 10, 2026). The IAF is procuring 56 C-295 ...

As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals(NASDAQ:RXRX) and Schrödinger(NASDAQ:SDGR) depends on ...

How did Brazil qualify?How did Brazil qualify? The FIFA World Cup 26 qualifiers in South America saw all ten CONMEBOL nations face off in a round-robin league format. Brazil finished fifth on 10 June ...

SALT LAKE CITY(AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $117.5 million in its first quarter. The Salt Lake City-based company said it had a ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

The Mass Production Array is the second sector in Pragmata, and it has six blocks: Test Site Entrance, Shopping District, Side Alley, Business District, Lim Recycling Factory, and Comms Tower. Here's ...

Behold the 2027 Mercedes-Benz C-Class EV, the all-electric-powered version of the C-Class sedan. It will be the second product to market following the GLC-Class SUV to be built on the all-new Mercedes ...

Greysun is the Lead Guides Editor at GameRant, where he oversees game help coverage for everything from the biggest AAA releases to standout indie and live-service titles. Professionally, Greysun has ...

Childbirth often goes differently than planned, but a Florida woman faced something truly unexpected while she was in labor: a virtual court hearing. Doyley's plan was to try for a vaginal birth, the ...

The streamer has tapped the once-exiled comedian to headline a show at The Hollywood Bowl and will premiere his upcoming standup special. By Katie Kilkenny Enterprise Reporter, TV & Labor The report ...

The consensus mark for RXRX's Q4 loss and sales are pinned at 28 cents per share and $25.5M, respectively. In late 2025, RXRX highlighted REC-4881 data showing rapid, durable polyp reductions in FAP ...